Moleculin Biotech, Inc.
MBRX
$0.9502
$0.07538.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.83% | -61.74% | -66.29% | -54.85% | -45.42% |
| Total Receivables | -79.80% | -- | -25.00% | -- | 350.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -72.82% | -27.22% | 5.54% | 5.39% | 27.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -39.27% | -- | -49.39% | -- | -31.96% |
| Total Current Assets | -80.23% | -57.95% | -61.19% | -51.75% | -42.38% |
|
|
|||||
| Total Current Assets | -80.23% | -57.95% | -61.19% | -51.75% | -42.38% |
| Net Property, Plant & Equipment | -26.76% | -17.10% | 18.57% | 18.40% | 17.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -55.71% | -40.81% | -45.72% | -39.59% | -33.45% |
|
|
|||||
| Total Accounts Payable | -18.73% | 26.99% | -31.50% | 8.51% | 19.24% |
| Total Accrued Expenses | -23.90% | 63.34% | 15.84% | 3.30% | 61.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.00% | 31.82% | -- | -- | -13.79% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -21.36% | 43.85% | -12.33% | 7.47% | 41.42% |
|
|
|||||
| Total Current Liabilities | -21.36% | 43.85% | -12.33% | 7.47% | 41.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.47% | -21.37% | 44.33% | 46.10% | 41.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.70% | 993,100.00% | 85,100.00% | 8,847.37% | 6,205.19% |
| Total Liabilities | -9.86% | 262.94% | 14.94% | 72.15% | 132.15% |
|
|
|||||
| Common Stock & APIC | 1.08% | 1.59% | 1.68% | 1.77% | 2.38% |
| Retained Earnings | -16.54% | -24.85% | -21.75% | -24.44% | -29.23% |
| Treasury Stock & Other | -355.56% | 233.33% | -242.86% | -325.00% | -175.00% |
| Total Common Equity | -77.07% | -78.72% | -56.03% | -52.75% | -50.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -77.07% | -78.72% | -56.03% | -52.75% | -50.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -77.07% | -78.72% | -56.03% | -52.75% | -50.04% |
|
|
|||||